病毒样蛋白纳米颗粒疫苗研究进展
Research progress in virus-like protein nanoparticle vaccines
杨静 1方谭玮 2徐涛3
作者信息
- 1. 岳阳市中心血站供血科,岳阳 414000
- 2. 湖南省胸科医院Ⅰ期临床试验研究室,长沙 410013
- 3. 长沙卫生职业学院基础医学部,长沙 410000
- 折叠
摘要
疫苗是应对传染病最有效的手段.有关疫苗及其技术的研究取得巨大的进展,其中,病毒样蛋白纳米颗粒疫苗(virus-like protein nanoparticle vaccine,VLPNV)以其独特的技术优势和良好抗感染免疫保护效果,成为疫苗研发热点,并取得了良好的应用效果.本文就VLPNV在引发免疫反应、表达技术以及防治病毒感染应用等方面的最新研究进展进行了综述,以期为VLPNV的未来设计和研发提供参考.
Abstract
Vaccines are the most effective means of combating infectious diseases.Great progress has been made in the research of vaccines and their technologies.Among them,virus-like protein nanoparticle vaccine(VLPNV)has become a hot spot of vaccine research and development with its unique technical advantages and better anti-infection immune protection effects,and has achieved good application effects.In this paper,the latest research progress of virus-like nanoparticle vaccines in inducing immune response,VLPNV expression technology and preventing and treating virus infection has been reviewed,so as to provide the reference for the future design and development of VLPNV.
关键词
疫苗/病毒样蛋白纳米颗粒疫苗/免疫反应Key words
Vaccine/Virus-like protein nanoparticle vaccine/Immune response引用本文复制引用
基金项目
湖南省中医药科研项目(B20240110)
出版年
2024
NETL
NSTL
万方数据